Patent · US Active

Tryptamide compositions and methods of use

US10314817B2 · kind B2 · utility

0Cited by

0References

14Claims

0Family size

Assignee

Signum Biosciences, Inc. · US

Inventors

Jeffry B. Stock · Princeton, US
Maxwell Stock · Boulder, US
Michael Voronkov · Cranbury, US
Jose Fernandez · Monmouth Junction, US
Kristen Huber · Monmouth Junction, US

Key dates

Filing date	Oct 15, 2015
Grant date	Jun 11, 2019
Priority date	—
Expiry date	Oct 15, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D209/16
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

EHT extract including a mixture of late eluting tryptamides and early eluting tryptamides in a weight ratio of at least about 7:1 late eluting tryptamides:early eluting tryptamides, wherein the EHT extract includes at least 30% eicosanoyl-5-hydroxytryptamide, based on the total weight of the tryptamides in the EHT extract.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.